Delivery Order SPE2DB20D2104-SPE2DB25FMZMC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,705.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The award, issued on July 24, 2025, with completion targeted for July 25, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,017.91 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, employs firm fixed pricing with no set-aside designation, indicating competitive award conditions. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $3,931.20 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely used anticoagulant medication. This competitively awarded, firm fixed-price contract, issued on August 26, 2025, with completion targeted for August 27, 2025, represents a small-value pharmaceutical supply transaction. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this...
- The Defense Logistics Agency awarded a $11,793.60 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Eliquis 2.5 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with a completion date of September 17, 2025, and performance will be conducted at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. This award...
- The Defense Logistics Agency awarded a delivery order valued at $6,506.70 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The order was competitively awarded as a firm fixed-price delivery order with no set-aside designation and an ultimate completion date of June 4, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $4,914.00 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a commonly prescribed anticoagulant medication. The contract is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and was competitively awarded without set-aside restrictions. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely prescribed anticoagulant medication. This firm fixed-price delivery order, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a small-value pharmaceutical procurement issued under a non-competitive set-aside arrangement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $4,097.65 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Eliquis 2.5 mg tablets in quantities of 60 units. The contract is a firm fixed price delivery order with an ultimate completion date of September 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award carries no set-aside designation and was competitively awarded, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.50 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a anticoagulant medication commonly used in military and veteran healthcare systems. This competitively awarded, firm fixed-price delivery order was issued on January 30, 2025, with an ultimate completion date of January 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) on July 29, 2025, with completion targeted for July 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical will be delivered to the Conshohocken, Pennsylvania location, which serves as AmerisourceBergen's corporate headquarters and primary distribution...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMZMCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely used anticoagulant medication. The award, made on September 4, 2025, with completion targeted for September 5, 2025, utilizes a firm fixed price structure with no set-aside designation, indicating competitive award status. The pharmaceutical will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the Defense Logistics Agency's medical supply chain operations. This delivery order represents a drawdown against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of medications and medical commodities to support military and veteran healthcare systems. The company's extensive portfolio of competitively awarded federal contracts demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 9/4/25 |